Repopulation of circulating T, B and NK lymphocytes following bone marrow and blood stem cell transplantation

Hematology and Cell Therapy

Volumn 39, Issue 6, 1997, Pages 301-306

  Parrado, A ^a,b   Casares, S ^a,c   Prieto, J ^a,d   Carmona, M ^a   Vaquero, A ^a   Rodriguez Fernandez J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b SAINT LOUIS HOSPITAL   (France)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Hospital Comarcal de Melilla   (Spain)

Author keywords

ABMT; Allogeneic BMT; Lymphocyte subsets; NK cells; PBSCT

Indexed keywords

BUSULFAN; CARMUSTINE; CD16 ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DQ ANTIGEN; HLA DR ANTIGEN; IFOSFAMIDE; INTERLEUKIN 2 RECEPTOR; METHYLPREDNISOLONE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LEUKEMIA; LYMPHOCYTE SUBPOPULATION; LYMPHOMA; NATURAL KILLER CELL; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA-D ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 0031456808     PISSN: 12693286     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-997-0301-3     Document Type: Article

References (30)

1. Ashihara E, Shimazaki C, Yamagata N, et al. (1994) Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis. Bone Marrow Transplant 13: 377-381
2. Autran B, Leblond V, Sadat-Sowti B, et al. (1991) A soluble factor released by CD8+CD57+ lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. Blood 77: 2237-2241
3. Bengtsson M, Smedmyr B, Festin R, et al. (1989) B lymphocyte regeneration in marrow and blood after autologous bone marrow transplantation: increased numbers of B cells carrying activation and progression markers. Leukemia Res 13: 791-797
4. Bengtsson M, Tötterman TH, Smedmyr B, et al. (1989) Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis. Leukemia 3: 68-75
5. Dolstra H, Preijers F, Van de Wiel-van Kemenade E, et al. (1995) Expansion of CD8+CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection. Br J Haematol 90: 300-307
6. Dombret H (1996) Granulocytic colony-stimulating factors in the management of patients with acute leukemia. Hematol Cell Ther 38: 231-240
7. Fegan C, Thomas H, Bailey-Wood R, et al. (1995) In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation. Bone Marrow Transplant 16: 277-281
8. Friedrich W, O'Reilly RJ, Koziner B, et al. (1982) T-lymphocyte reconstitution in recipients of bone marrow transplants with and without GVHD: imbalances of T-cell subpopulations having unique regulatory and cognitive functions. Blood 59: 696-701
9. Fukuda H, Nakamura H, Tominaga N, et al. (1994) Marked increase of CD8+S6F1+ and CD8+CD57+ cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 13: 181-185
10. Gisselbrecht C (1996) Autologous stem cell transplantation in aggressive non-Hodgkin's lymphoma. Hematol Cell Ther 38: 297-304
11. Higuchi CM, Thompson JA, Cox T, et al. (1989) Lymphokine-activated killer function following autologous bone marrow transplantation for refractory hematological malignancies. Cancer Res 49: 5509-5513
12. Hokland M, Jacobsen N, Ellegaard J, et al. (1988) Natural killer function following allogeneic bone marrow transplantation. Very early reemergence but strong dependence of cytomegalovirus infection. Transplantation 45: 1080-1084
13. Izquierdo M, Balboa MA, Fernández-Ranada JM, et al. (1988) Natural killer function following allogeneic bone marrow+CD57+ lymphocytes and T cell dysfunction in recipients of bone marrow transplantation. Clin Exp Immunol 81: 145-150
14. Jiang YZ, Barrett AJ, Goldman JM, et al. (1997) Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation. Ann Hematol 74: 1-6
15. Keever CA, Klein J, Leong N, et al. (1993) Effect of GVHD on the recovery of NK cell activity and LAK precursors following BMT. Bone Marrow Transplant 12: 289-295
16. Leino L, Lilius EM, Nikoskelainen J, et al. (1991) The reappearance of 10 differentiation antigens on peripheral blood lymphocytes after allogeneic bone marrow transplantation. Bone Marrow Transplant 8: 339-344
17. Lopez-Jiménez J, Pérez-Oteyza J, Munoz A, et al. (1997) Subcutaneous versus intravenous low-dose IL-2 therapy after autologous transplantation: results of a prospective non-randomized study. Bone Marrow Transplant 19: 429-434
18. Parrado A, Casares S, Rodríguez-Fernández JM (1994) Natural killer cytotoxicity and lymphocyte subpopulations in patients with acute leukemia. Leukemia Res 18: 191-197
19. Parrado A, Casares S, Rodríguez-Fernández JM (1994) Lymphokine-activated killer cytotoxicity and lymphocyte subpopulations in patients with acute leukemia. Leukemia Res 18: 815-822
20. Parrado A, Rodríguez-Fernández JM, Casares S, et al. (1993) Generation of LAK cells in vitro in patients with acute leukemia. Leukemia 7: 1344-1348
21. Roberts MM, To LB, Gillis D, et al. (1993) Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 12: 469-475
22. Reiffers J, Stoppa AM, Attal M, et al. (1993) Autologous stem cell transplantation versus chemotherapy for adult patients with acute myeloid leukemia in first remission: the BGMT group experience. Nouv Rev Fr Hematol 35: 17-19
23. Robinson N, Benyunes MC, Thompson JA, et al. (1997) Interleukin- 2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study. Bone Marrow Transplant 17: 435-442
24. Rosillo MC, Ortunc F, Moraleda JM, et al. (1996) Immune recovery after autologous or rhG-CSF primed PBSC transplantation. Eur J Haematol 56: 301-307
25. San Miguel JF, Hernández MD, Gonzalez M, et al. (1996) A randomized study comparing the effect of GM-CSF and G-CSF on immune reconstitution after autologous bone marrow transplantation. Br J Haematol 94: 140-147
26. Schmidt RE, Murray C, Daley JF, et al. (1986) A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. J Exp Med 164: 351-356
27. Smedmyr B, Bengtsson M, Jakobsson A, et al. (1991) Regeneration of CALLA (CD10+), TdT+ and double-positive cells in the bone marrow and blood after autologous bone marrow transplantation. Eur J Haematol 46: 146-151
28. Storek J, Saxon A (1992) Reconstitution of B cell immunity following bone marrow transplantation. Bone Marrow Transplant 9: 395-408
29. Sugita K, Soiffer RJ, Murray C, et al. (1994) The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation. Transplantation 57: 1465-1473
30. Talmadge JE, Reed E, Ino K, et al. (1997) Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 19: 161-172